All Products
Muscle Tissue, Recovery & GH Axis Studies

CJC-1295 no dac

Product Summary
Regular price $34.99 USD
Regular price Sale price $34.99 USD
Sale Sold out
Vial Size

99% Pure Lyophilized Powder in 3ml vial (NOT A LIQUID) – If Reconstitution is desired, please purchase our Reconstitution Solution, HERE

View full details

Want a shortcut to research?

Download Our eBook Library →

Dispatched Within 24 Hours

Referenced in Human Studies

Third-Party COA Verified

Sourced from Trusted Labs in EU

Scientific Advisory Oversight

Description
Storage
Peptide structure
Delivery & Shipping Info
Research use

CJC-1295 No DAC is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.

Frequently Asked Questions

Our local team are here to help

Have more questions about peptide research? You’re not alone. Explore our Frequently Asked Questions for quick answers—or head to the Knowledge Base to explore study areas, calculators, and protocol guides.

SEE ALL FAQS
What is CJC-1295 without DAC used for in research?
Chevron icon SVG

CJC-1295 no DAC is studied for its ability to mimic natural growth hormone pulses in short-duration research protocols.

How does CJC-1295 no DAC differ from the DAC version?
Chevron icon SVG

The no DAC version has a shorter half-life, requiring more frequent dosing in GH-related studies.

How is CJC-1295 no DAC typically combined in research?
Chevron icon SVG

It’s often paired with Ipamorelin to study dual-pathway stimulation of growth hormone release.

What are the storage recommendations for CJC-1295 no DAC?
Chevron icon SVG

Store vials in a cool, dry place. Once mixed, keep refrigerated and use within 30 days.

How often is CJC-1295 no DAC used in research settings?
Chevron icon SVG

Once or twice daily administration is common in preclinical protocols focused on pulsatile GH support.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)